CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Predictive and prognostic impact of blood-based inflammatory biomarkers in patients with gastroenteropancreatic neuroendocrine tumors commencing peptide receptor radionuclide therapy
DOI 10.1055/s-0040-1708392
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Ohlendorf, R Werner, C Henkenberens, TL Ross, H Christiansen, FM Bengel, T Derlin
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Predictive and prognostic impact of blood-based inflammatory biomarkers in patients with gastroenteropancreatic neuroendocrine tumors commencing peptide receptor radionuclide therapy
Zitieren
Zitierempfehlung
F Ohlendorf, R Werner, C Henkenberens, TL Ross, H Christiansen, FM Bengel, T Derlin (2020) Predictive and prognostic impact of blood-based inflammatory biomarkers in patients with gastroenteropancreatic neuroendocrine tumors commencing peptide receptor radionuclide therapy. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708392
Mit CareLit weiterarbeiten